| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle Proteins | 86 | 2013 | 1152 | 6.530 |
Why?
|
| Muscle, Skeletal | 66 | 2014 | 4924 | 4.110 |
Why?
|
| Sepsis | 68 | 2013 | 2592 | 3.990 |
Why?
|
| Muscular Atrophy | 17 | 2013 | 331 | 3.890 |
Why?
|
| Muscle Fibers, Skeletal | 19 | 2013 | 542 | 3.770 |
Why?
|
| Dexamethasone | 23 | 2013 | 1927 | 2.940 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 16 | 2013 | 174 | 2.910 |
Why?
|
| Multienzyme Complexes | 23 | 2004 | 666 | 2.770 |
Why?
|
| Cysteine Endopeptidases | 23 | 2008 | 548 | 2.600 |
Why?
|
| Interleukin-1 | 37 | 2004 | 1249 | 2.520 |
Why?
|
| Glucocorticoids | 28 | 2013 | 2145 | 2.400 |
Why?
|
| Interleukin-6 | 30 | 2007 | 3215 | 2.300 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 10 | 2011 | 102 | 2.270 |
Why?
|
| Intestinal Mucosa | 35 | 2002 | 3022 | 1.980 |
Why?
|
| Muscles | 55 | 2013 | 1581 | 1.910 |
Why?
|
| Ubiquitin-Protein Ligases | 20 | 2013 | 1888 | 1.900 |
Why?
|
| Calpain | 13 | 2011 | 145 | 1.840 |
Why?
|
| NF-kappa B | 20 | 2008 | 2486 | 1.720 |
Why?
|
| Ubiquitins | 23 | 2007 | 370 | 1.690 |
Why?
|
| Endotoxemia | 11 | 2002 | 196 | 1.670 |
Why?
|
| Rats | 161 | 2013 | 23709 | 1.620 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 11 | 2007 | 286 | 1.370 |
Why?
|
| Rats, Sprague-Dawley | 69 | 2013 | 8158 | 1.330 |
Why?
|
| Enterocytes | 12 | 2007 | 220 | 1.250 |
Why?
|
| Heat-Shock Response | 7 | 2002 | 179 | 1.210 |
Why?
|
| RNA, Messenger | 54 | 2013 | 12762 | 1.160 |
Why?
|
| Bacterial Infections | 25 | 2008 | 1403 | 1.140 |
Why?
|
| Protein Biosynthesis | 35 | 2013 | 2104 | 1.130 |
Why?
|
| Proteasome Endopeptidase Complex | 29 | 2011 | 1313 | 1.040 |
Why?
|
| Adenocarcinoma, Follicular | 3 | 2021 | 325 | 1.030 |
Why?
|
| Caco-2 Cells | 20 | 2007 | 368 | 1.020 |
Why?
|
| Insulin-Like Growth Factor I | 13 | 2007 | 1928 | 0.960 |
Why?
|
| Parathyroid Neoplasms | 4 | 2011 | 241 | 0.950 |
Why?
|
| Burns | 16 | 2007 | 1866 | 0.930 |
Why?
|
| Valerates | 2 | 2013 | 20 | 0.880 |
Why?
|
| Ligases | 6 | 2003 | 332 | 0.870 |
Why?
|
| Down-Regulation | 10 | 2010 | 2913 | 0.870 |
Why?
|
| Complement C3 | 8 | 2000 | 451 | 0.850 |
Why?
|
| Thyroid Neoplasms | 7 | 2021 | 2332 | 0.840 |
Why?
|
| Hyperthyroidism | 10 | 2009 | 291 | 0.820 |
Why?
|
| Arsenites | 7 | 2003 | 65 | 0.810 |
Why?
|
| Receptors, Glucocorticoid | 12 | 2013 | 296 | 0.790 |
Why?
|
| Transcription Factors | 19 | 2012 | 12102 | 0.790 |
Why?
|
| Muscle Fibers, Fast-Twitch | 4 | 2013 | 70 | 0.760 |
Why?
|
| Jejunum | 10 | 2000 | 471 | 0.760 |
Why?
|
| Mifepristone | 15 | 2012 | 150 | 0.750 |
Why?
|
| Peptide Hydrolases | 8 | 2008 | 623 | 0.750 |
Why?
|
| Animals | 212 | 2013 | 167960 | 0.730 |
Why?
|
| Liver | 45 | 2002 | 7510 | 0.720 |
Why?
|
| Smallpox | 1 | 2020 | 43 | 0.720 |
Why?
|
| I-kappa B Proteins | 7 | 2004 | 212 | 0.700 |
Why?
|
| Up-Regulation | 16 | 2013 | 4122 | 0.690 |
Why?
|
| Rats, Inbred Strains | 65 | 1992 | 2094 | 0.680 |
Why?
|
| Amino Acids | 32 | 1999 | 1714 | 0.670 |
Why?
|
| Histone Deacetylases | 4 | 2012 | 718 | 0.660 |
Why?
|
| Cachexia | 10 | 2004 | 198 | 0.650 |
Why?
|
| Forkhead Transcription Factors | 6 | 2013 | 1613 | 0.650 |
Why?
|
| Glycogen Synthase Kinase 3 | 5 | 2013 | 410 | 0.650 |
Why?
|
| Sodium Compounds | 6 | 2003 | 35 | 0.630 |
Why?
|
| Acetylation | 6 | 2012 | 1062 | 0.610 |
Why?
|
| Gene Expression Regulation | 15 | 2013 | 11902 | 0.610 |
Why?
|
| Thyroid Nodule | 3 | 2021 | 760 | 0.610 |
Why?
|
| Parathyroidectomy | 2 | 2011 | 241 | 0.600 |
Why?
|
| Cysteine Proteinase Inhibitors | 8 | 2006 | 189 | 0.600 |
Why?
|
| Leupeptins | 11 | 2003 | 113 | 0.590 |
Why?
|
| Hyperparathyroidism, Primary | 3 | 2011 | 161 | 0.590 |
Why?
|
| Adenoma | 6 | 2016 | 2148 | 0.590 |
Why?
|
| Histone Acetyltransferases | 2 | 2012 | 337 | 0.580 |
Why?
|
| Curcumin | 2 | 2008 | 99 | 0.570 |
Why?
|
| Wasting Syndrome | 2 | 2008 | 98 | 0.570 |
Why?
|
| Transcription Factor AP-1 | 4 | 2003 | 321 | 0.570 |
Why?
|
| Ubiquitin | 9 | 2013 | 838 | 0.570 |
Why?
|
| Energy Metabolism | 17 | 2016 | 2869 | 0.550 |
Why?
|
| Acetylcysteine | 4 | 2002 | 264 | 0.530 |
Why?
|
| Calcium | 15 | 2011 | 5725 | 0.530 |
Why?
|
| Immunization | 1 | 2020 | 1227 | 0.530 |
Why?
|
| Corticosterone | 14 | 2008 | 303 | 0.520 |
Why?
|
| Proteins | 21 | 2006 | 6029 | 0.500 |
Why?
|
| E1A-Associated p300 Protein | 3 | 2010 | 123 | 0.490 |
Why?
|
| Hyperparathyroidism | 3 | 2011 | 339 | 0.480 |
Why?
|
| Parathyroid Hormone | 3 | 2011 | 1797 | 0.480 |
Why?
|
| Escherichia coli Infections | 7 | 2000 | 523 | 0.470 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2013 | 173 | 0.470 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 1974 | 0.450 |
Why?
|
| Myofibrils | 13 | 2000 | 141 | 0.450 |
Why?
|
| Physician's Role | 1 | 2020 | 918 | 0.440 |
Why?
|
| PPAR-beta | 1 | 2013 | 4 | 0.440 |
Why?
|
| Gene Expression Regulation, Enzymologic | 7 | 2010 | 1173 | 0.440 |
Why?
|
| Methylhistidines | 13 | 1998 | 35 | 0.440 |
Why?
|
| Ischemia | 15 | 1991 | 1893 | 0.440 |
Why?
|
| Sirtuin 1 | 2 | 2011 | 247 | 0.430 |
Why?
|
| PPAR delta | 1 | 2013 | 40 | 0.430 |
Why?
|
| Blotting, Western | 14 | 2014 | 5039 | 0.430 |
Why?
|
| Endotoxins | 9 | 1998 | 521 | 0.430 |
Why?
|
| Cell Line | 17 | 2013 | 15620 | 0.400 |
Why?
|
| Dantrolene | 2 | 2002 | 26 | 0.400 |
Why?
|
| Carcinoma | 2 | 2016 | 2331 | 0.400 |
Why?
|
| Nerve Tissue Proteins | 7 | 2013 | 4408 | 0.400 |
Why?
|
| Glutamine | 6 | 1999 | 576 | 0.390 |
Why?
|
| Carcinoma, Papillary | 4 | 2016 | 785 | 0.390 |
Why?
|
| Male | 192 | 2021 | 359718 | 0.380 |
Why?
|
| Caspases | 2 | 2004 | 878 | 0.380 |
Why?
|
| Gene Expression | 14 | 2013 | 7587 | 0.380 |
Why?
|
| Caloric Restriction | 1 | 2013 | 295 | 0.380 |
Why?
|
| Tyrosine | 20 | 1998 | 1438 | 0.370 |
Why?
|
| Physical Endurance | 1 | 2013 | 363 | 0.370 |
Why?
|
| Stilbenes | 1 | 2011 | 155 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 17 | 2001 | 4356 | 0.370 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 1758 | 0.370 |
Why?
|
| Transcription, Genetic | 12 | 2011 | 7593 | 0.360 |
Why?
|
| Heat-Shock Proteins | 5 | 2007 | 795 | 0.360 |
Why?
|
| RNA, Small Interfering | 9 | 2013 | 3442 | 0.360 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2012 | 1796 | 0.340 |
Why?
|
| Physical Conditioning, Animal | 1 | 2013 | 366 | 0.340 |
Why?
|
| Phospholipases A2 | 1 | 2010 | 197 | 0.340 |
Why?
|
| Enzyme Inhibitors | 11 | 2006 | 3725 | 0.340 |
Why?
|
| Myostatin | 1 | 2010 | 127 | 0.330 |
Why?
|
| Metoprolol | 8 | 1987 | 92 | 0.330 |
Why?
|
| Muscle Fibers, Slow-Twitch | 3 | 1999 | 52 | 0.330 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2004 | 1246 | 0.330 |
Why?
|
| Leucine | 14 | 2007 | 547 | 0.330 |
Why?
|
| Wounds and Injuries | 9 | 2008 | 2477 | 0.320 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2021 | 1110 | 0.310 |
Why?
|
| Phosphorylation | 6 | 2013 | 8311 | 0.310 |
Why?
|
| Serum Amyloid A Protein | 2 | 1998 | 127 | 0.310 |
Why?
|
| Dinoprostone | 8 | 1997 | 598 | 0.310 |
Why?
|
| Hormone Antagonists | 6 | 2010 | 108 | 0.310 |
Why?
|
| Trans-Activators | 2 | 2010 | 2860 | 0.300 |
Why?
|
| Muscle Strength | 1 | 2012 | 619 | 0.300 |
Why?
|
| Cell Size | 3 | 2012 | 624 | 0.300 |
Why?
|
| Lactones | 3 | 2006 | 319 | 0.300 |
Why?
|
| Indomethacin | 7 | 1995 | 326 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 16 | 2008 | 10826 | 0.300 |
Why?
|
| Blotting, Northern | 9 | 2000 | 1543 | 0.290 |
Why?
|
| Oligopeptides | 4 | 2004 | 1187 | 0.290 |
Why?
|
| Mice, Inbred A | 7 | 2000 | 246 | 0.290 |
Why?
|
| Epithelial Cells | 6 | 2002 | 3663 | 0.280 |
Why?
|
| Digestive System | 2 | 2000 | 244 | 0.280 |
Why?
|
| Cells, Cultured | 20 | 2014 | 18955 | 0.280 |
Why?
|
| Polyamines | 3 | 1996 | 133 | 0.280 |
Why?
|
| Cecum | 13 | 2002 | 232 | 0.280 |
Why?
|
| Cell Nucleus | 9 | 2013 | 2907 | 0.280 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 5 | 2005 | 26 | 0.270 |
Why?
|
| Cycloheximide | 4 | 2004 | 343 | 0.270 |
Why?
|
| Intestine, Small | 5 | 2002 | 1207 | 0.260 |
Why?
|
| Ligation | 16 | 2002 | 448 | 0.260 |
Why?
|
| Thyroidectomy | 8 | 2021 | 902 | 0.260 |
Why?
|
| Triiodothyronine | 8 | 1987 | 493 | 0.260 |
Why?
|
| Calcium Signaling | 1 | 2010 | 732 | 0.250 |
Why?
|
| DNA-Binding Proteins | 8 | 2010 | 9591 | 0.250 |
Why?
|
| Lysosomes | 4 | 2009 | 920 | 0.250 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 687 | 0.240 |
Why?
|
| Hot Temperature | 5 | 2003 | 1435 | 0.240 |
Why?
|
| Calcimycin | 1 | 2004 | 213 | 0.240 |
Why?
|
| Hyperthermia, Induced | 3 | 2002 | 417 | 0.230 |
Why?
|
| Adrenergic beta-Antagonists | 5 | 1988 | 1259 | 0.230 |
Why?
|
| Stress, Physiological | 2 | 2002 | 1398 | 0.230 |
Why?
|
| Muscle Relaxants, Central | 2 | 2002 | 92 | 0.230 |
Why?
|
| Nutrition Disorders | 2 | 2002 | 205 | 0.220 |
Why?
|
| Permeability | 3 | 2002 | 719 | 0.220 |
Why?
|
| Liver Circulation | 8 | 1987 | 159 | 0.220 |
Why?
|
| Probiotics | 1 | 2007 | 377 | 0.220 |
Why?
|
| Lipopolysaccharides | 7 | 2002 | 2209 | 0.220 |
Why?
|
| Calcium-Binding Proteins | 2 | 2006 | 1067 | 0.220 |
Why?
|
| HSP70 Heat-Shock Proteins | 5 | 2007 | 397 | 0.220 |
Why?
|
| Transfection | 7 | 2006 | 5781 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 489 | 0.210 |
Why?
|
| Ubiquitination | 1 | 2007 | 1008 | 0.210 |
Why?
|
| Histidine | 3 | 1990 | 311 | 0.210 |
Why?
|
| DNA | 12 | 2006 | 7233 | 0.210 |
Why?
|
| Electrophoretic Mobility Shift Assay | 4 | 2004 | 295 | 0.210 |
Why?
|
| Ornithine Decarboxylase | 4 | 1996 | 64 | 0.200 |
Why?
|
| Cytokines | 11 | 2004 | 7344 | 0.200 |
Why?
|
| Recombinant Proteins | 18 | 2002 | 6538 | 0.200 |
Why?
|
| Thiocarbamates | 3 | 2000 | 30 | 0.200 |
Why?
|
| Humans | 113 | 2021 | 760613 | 0.190 |
Why?
|
| General Surgery | 2 | 2004 | 1678 | 0.190 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 999 | 0.190 |
Why?
|
| Glycoproteins | 2 | 2006 | 2208 | 0.190 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1894 | 0.190 |
Why?
|
| Gastrointestinal Hormones | 3 | 2002 | 100 | 0.190 |
Why?
|
| Flavonoids | 5 | 2005 | 445 | 0.180 |
Why?
|
| Insulin | 10 | 2007 | 6596 | 0.180 |
Why?
|
| Shock | 2 | 2002 | 317 | 0.180 |
Why?
|
| Base Sequence | 10 | 2005 | 12444 | 0.180 |
Why?
|
| Putrescine | 3 | 1996 | 42 | 0.180 |
Why?
|
| Intestinal Absorption | 1 | 2001 | 400 | 0.180 |
Why?
|
| Serine Endopeptidases | 2 | 2002 | 1021 | 0.180 |
Why?
|
| Peritonitis | 3 | 2013 | 369 | 0.170 |
Why?
|
| DNA Primers | 5 | 2005 | 2818 | 0.170 |
Why?
|
| History, 18th Century | 1 | 2020 | 207 | 0.170 |
Why?
|
| Interleukin-10 | 2 | 2002 | 1174 | 0.170 |
Why?
|
| Coumarins | 1 | 2000 | 119 | 0.170 |
Why?
|
| Transcription Factor CHOP | 3 | 2006 | 68 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 3 | 2005 | 1483 | 0.170 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 1266 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 8512 | 0.170 |
Why?
|
| Dipeptides | 3 | 2006 | 410 | 0.170 |
Why?
|
| Propranolol | 5 | 1987 | 489 | 0.160 |
Why?
|
| Adipose Tissue, Brown | 2 | 2016 | 755 | 0.160 |
Why?
|
| Mass Vaccination | 1 | 2020 | 109 | 0.160 |
Why?
|
| Cathepsin L | 2 | 2009 | 68 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 4571 | 0.160 |
Why?
|
| Dysphonia | 1 | 2021 | 144 | 0.160 |
Why?
|
| Hepatic Artery | 6 | 1985 | 230 | 0.160 |
Why?
|
| Hindlimb | 7 | 2005 | 510 | 0.160 |
Why?
|
| Transcriptional Activation | 3 | 2002 | 1754 | 0.160 |
Why?
|
| p300-CBP Transcription Factors | 2 | 2012 | 150 | 0.160 |
Why?
|
| Keto Acids | 2 | 1988 | 34 | 0.160 |
Why?
|
| Cyclic AMP | 1 | 2002 | 1456 | 0.160 |
Why?
|
| Breast | 2 | 2000 | 1963 | 0.150 |
Why?
|
| RNA Interference | 3 | 2012 | 2846 | 0.150 |
Why?
|
| Mice | 23 | 2013 | 81209 | 0.150 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2003 | 621 | 0.150 |
Why?
|
| Methimazole | 2 | 1987 | 41 | 0.150 |
Why?
|
| Neurosecretory Systems | 1 | 1999 | 221 | 0.140 |
Why?
|
| Phenylalanine | 8 | 1998 | 365 | 0.140 |
Why?
|
| Cell Cycle Proteins | 2 | 2006 | 3448 | 0.140 |
Why?
|
| HSP72 Heat-Shock Proteins | 3 | 2002 | 41 | 0.140 |
Why?
|
| Muscular Diseases | 2 | 2000 | 551 | 0.140 |
Why?
|
| Mice, Inbred Strains | 4 | 2002 | 1763 | 0.140 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1996 | 477 | 0.140 |
Why?
|
| Adenosine Triphosphate | 11 | 1998 | 1993 | 0.140 |
Why?
|
| Hydrolysis | 4 | 2002 | 665 | 0.140 |
Why?
|
| Thiadiazoles | 3 | 2005 | 64 | 0.140 |
Why?
|
| Lithium Chloride | 3 | 2005 | 82 | 0.140 |
Why?
|
| Surgical Wound Infection | 6 | 1984 | 1527 | 0.140 |
Why?
|
| Antithyroid Agents | 2 | 1988 | 72 | 0.140 |
Why?
|
| Enzyme Activation | 5 | 2011 | 3602 | 0.140 |
Why?
|
| Time Factors | 21 | 2021 | 40139 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 3 | 2002 | 5782 | 0.140 |
Why?
|
| Apolipoproteins | 1 | 1998 | 320 | 0.130 |
Why?
|
| Sialoglycoproteins | 2 | 1994 | 315 | 0.130 |
Why?
|
| Thyrotoxicosis | 1 | 2016 | 85 | 0.130 |
Why?
|
| Carcinoma, Lobular | 1 | 2000 | 489 | 0.130 |
Why?
|
| Nuclear Proteins | 3 | 2007 | 5795 | 0.130 |
Why?
|
| Dactinomycin | 3 | 2004 | 304 | 0.130 |
Why?
|
| Turpentine | 1 | 1995 | 10 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 6 | 2005 | 6065 | 0.130 |
Why?
|
| Hydroxamic Acids | 2 | 2010 | 482 | 0.130 |
Why?
|
| Nutritional Support | 3 | 2002 | 172 | 0.130 |
Why?
|
| Tritium | 5 | 2002 | 707 | 0.120 |
Why?
|
| Caspase 3 | 2 | 2009 | 730 | 0.120 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 3 | 2000 | 198 | 0.120 |
Why?
|
| Peptide Biosynthesis | 1 | 1994 | 52 | 0.120 |
Why?
|
| Interferon-gamma | 3 | 1997 | 3157 | 0.120 |
Why?
|
| Thermogenesis | 2 | 2016 | 468 | 0.120 |
Why?
|
| Temperature | 4 | 2003 | 2221 | 0.120 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 1994 | 149 | 0.120 |
Why?
|
| Ileum | 4 | 2001 | 555 | 0.120 |
Why?
|
| Protein Isoforms | 3 | 2006 | 1697 | 0.120 |
Why?
|
| Preoperative Care | 7 | 1995 | 2255 | 0.120 |
Why?
|
| Quercetin | 2 | 2007 | 97 | 0.120 |
Why?
|
| Interleukins | 2 | 1997 | 786 | 0.120 |
Why?
|
| Acute-Phase Proteins | 6 | 1996 | 250 | 0.120 |
Why?
|
| Aminoisobutyric Acids | 8 | 1993 | 39 | 0.120 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1994 | 180 | 0.110 |
Why?
|
| Hemodynamics | 5 | 1990 | 4173 | 0.110 |
Why?
|
| Prostaglandins E | 3 | 1988 | 169 | 0.110 |
Why?
|
| Methylprednisolone | 2 | 1986 | 384 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1994 | 261 | 0.110 |
Why?
|
| Serum Response Factor | 1 | 2013 | 78 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 5 | 2002 | 6130 | 0.110 |
Why?
|
| Middle Aged | 41 | 2021 | 220359 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2002 | 2138 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2000 | 1096 | 0.110 |
Why?
|
| Organ Size | 5 | 2010 | 2254 | 0.110 |
Why?
|
| Serum Albumin | 2 | 1995 | 674 | 0.100 |
Why?
|
| Protein Binding | 5 | 2005 | 9335 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2003 | 2982 | 0.100 |
Why?
|
| Muscle Cells | 1 | 2013 | 195 | 0.100 |
Why?
|
| Escherichia coli | 6 | 2007 | 4219 | 0.100 |
Why?
|
| Cathepsin B | 4 | 1998 | 80 | 0.100 |
Why?
|
| Reference Values | 10 | 1998 | 4925 | 0.100 |
Why?
|
| Actomyosin | 1 | 2012 | 109 | 0.100 |
Why?
|
| Aminopeptidases | 2 | 2002 | 95 | 0.100 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 2 | 2002 | 91 | 0.100 |
Why?
|
| Nitric Oxide | 3 | 1995 | 2141 | 0.100 |
Why?
|
| Hypothyroidism | 1 | 2016 | 665 | 0.100 |
Why?
|
| Nutrition Assessment | 1 | 1995 | 727 | 0.100 |
Why?
|
| Thyroxine | 4 | 1988 | 667 | 0.090 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 1988 | 263 | 0.090 |
Why?
|
| Liver Diseases | 3 | 1995 | 1302 | 0.090 |
Why?
|
| Shock, Septic | 4 | 1996 | 760 | 0.090 |
Why?
|
| Luciferases | 2 | 2003 | 716 | 0.090 |
Why?
|
| Chloralose | 1 | 1990 | 14 | 0.090 |
Why?
|
| Myogenin | 1 | 2010 | 55 | 0.090 |
Why?
|
| Gastric Mucosa | 3 | 2000 | 599 | 0.090 |
Why?
|
| Parathyroid Glands | 1 | 1992 | 517 | 0.090 |
Why?
|
| Adenine Nucleotides | 5 | 1990 | 111 | 0.090 |
Why?
|
| Culture Techniques | 4 | 2001 | 530 | 0.090 |
Why?
|
| Punctures | 6 | 1998 | 368 | 0.090 |
Why?
|
| Smad Proteins | 1 | 2010 | 156 | 0.090 |
Why?
|
| Aged | 31 | 2021 | 169143 | 0.090 |
Why?
|
| Pentobarbital | 1 | 1990 | 153 | 0.090 |
Why?
|
| Arachidonic Acids | 1 | 1990 | 294 | 0.090 |
Why?
|
| MyoD Protein | 1 | 2010 | 142 | 0.090 |
Why?
|
| Follistatin | 1 | 2010 | 137 | 0.090 |
Why?
|
| Colon | 4 | 2000 | 1788 | 0.090 |
Why?
|
| Hydrogen Peroxide | 2 | 2006 | 732 | 0.080 |
Why?
|
| Neoplasms | 4 | 2011 | 22075 | 0.080 |
Why?
|
| Signal Transduction | 9 | 2014 | 23374 | 0.080 |
Why?
|
| Aneurysm | 3 | 1985 | 337 | 0.080 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2002 | 586 | 0.080 |
Why?
|
| Muscle Weakness | 1 | 2012 | 413 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2021 | 80345 | 0.080 |
Why?
|
| Postoperative Complications | 7 | 2021 | 15679 | 0.080 |
Why?
|
| Activins | 1 | 2010 | 211 | 0.080 |
Why?
|
| Cell Survival | 4 | 2003 | 5797 | 0.080 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2009 | 173 | 0.080 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 290 | 0.080 |
Why?
|
| Female | 49 | 2021 | 391246 | 0.080 |
Why?
|
| Tosyllysine Chloromethyl Ketone | 2 | 1999 | 5 | 0.080 |
Why?
|
| Adult | 31 | 2021 | 220007 | 0.080 |
Why?
|
| Antibodies | 1 | 1997 | 2421 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2006 | 2471 | 0.080 |
Why?
|
| Molecular Sequence Data | 6 | 1996 | 17624 | 0.080 |
Why?
|
| Acute-Phase Reaction | 2 | 2000 | 91 | 0.080 |
Why?
|
| Intraoperative Period | 1 | 2009 | 516 | 0.080 |
Why?
|
| Diagnosis, Differential | 4 | 2016 | 12968 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 1993 | 1630 | 0.080 |
Why?
|
| Glutamate-Ammonia Ligase | 2 | 1999 | 72 | 0.080 |
Why?
|
| Genistein | 2 | 1999 | 86 | 0.080 |
Why?
|
| Kinetics | 5 | 2001 | 6377 | 0.080 |
Why?
|
| Pyrrolidines | 3 | 2000 | 340 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2448 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 3802 | 0.070 |
Why?
|
| Short Bowel Syndrome | 2 | 2002 | 353 | 0.070 |
Why?
|
| Neck Dissection | 1 | 2009 | 201 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 2 | 2001 | 412 | 0.070 |
Why?
|
| Hypercalcemia | 2 | 1992 | 421 | 0.070 |
Why?
|
| Premedication | 2 | 1988 | 253 | 0.070 |
Why?
|
| Nitrogen | 2 | 1988 | 350 | 0.070 |
Why?
|
| Mammography | 2 | 2000 | 2427 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2009 | 378 | 0.070 |
Why?
|
| Fasting | 2 | 2010 | 1603 | 0.070 |
Why?
|
| Disease Models, Animal | 8 | 2010 | 18137 | 0.070 |
Why?
|
| Glutathione | 1 | 1990 | 582 | 0.070 |
Why?
|
| Allopurinol | 2 | 1986 | 198 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1617 | 0.070 |
Why?
|
| Cytoplasm | 2 | 2003 | 1516 | 0.070 |
Why?
|
| Epithelium | 3 | 1997 | 1605 | 0.070 |
Why?
|
| Analysis of Variance | 5 | 2000 | 6238 | 0.070 |
Why?
|
| Cathepsins | 1 | 2008 | 242 | 0.070 |
Why?
|
| Nitroarginine | 3 | 1995 | 66 | 0.070 |
Why?
|
| Carcinoma, Medullary | 1 | 2007 | 115 | 0.070 |
Why?
|
| Sweden | 4 | 2004 | 1381 | 0.070 |
Why?
|
| Pepstatins | 1 | 2006 | 10 | 0.070 |
Why?
|
| Diethylcarbamazine | 1 | 1986 | 23 | 0.070 |
Why?
|
| Leptin | 1 | 2014 | 1590 | 0.070 |
Why?
|
| Arginine | 3 | 1995 | 934 | 0.070 |
Why?
|
| Shock, Traumatic | 1 | 1986 | 22 | 0.070 |
Why?
|
| Atrophy | 1 | 2011 | 1626 | 0.070 |
Why?
|
| Protease Inhibitors | 3 | 2004 | 755 | 0.070 |
Why?
|
| Thyrotropin | 1 | 2009 | 832 | 0.070 |
Why?
|
| Lactobacillus | 1 | 2007 | 204 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 2864 | 0.060 |
Why?
|
| Myoblasts, Skeletal | 1 | 2006 | 75 | 0.060 |
Why?
|
| Thymidine | 2 | 1997 | 299 | 0.060 |
Why?
|
| Models, Biological | 4 | 2007 | 9468 | 0.060 |
Why?
|
| Thiazoles | 1 | 2013 | 1511 | 0.060 |
Why?
|
| Sarcomeres | 1 | 2008 | 367 | 0.060 |
Why?
|
| Toes | 2 | 2005 | 209 | 0.060 |
Why?
|
| Dextrans | 3 | 2002 | 574 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 1975 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 772 | 0.060 |
Why?
|
| Horseradish Peroxidase | 2 | 2002 | 166 | 0.060 |
Why?
|
| History, 20th Century | 2 | 2004 | 2773 | 0.060 |
Why?
|
| Cefuroxime | 1 | 1984 | 23 | 0.060 |
Why?
|
| Biological Transport | 7 | 1999 | 2086 | 0.060 |
Why?
|
| Perfusion | 6 | 2001 | 1376 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 1999 | 1991 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2002 | 222 | 0.060 |
Why?
|
| Wounds, Stab | 2 | 1983 | 72 | 0.060 |
Why?
|
| Adaptation, Biological | 2 | 2002 | 147 | 0.060 |
Why?
|
| Hydralazine | 1 | 1984 | 36 | 0.060 |
Why?
|
| Molecular Probes | 2 | 1996 | 313 | 0.060 |
Why?
|
| Lactic Acid | 4 | 1997 | 1134 | 0.060 |
Why?
|
| Protein Transport | 1 | 2010 | 1964 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2000 | 1954 | 0.060 |
Why?
|
| Wounds, Gunshot | 4 | 1984 | 581 | 0.060 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 1983 | 29 | 0.060 |
Why?
|
| Colchicine | 2 | 1998 | 261 | 0.050 |
Why?
|
| Prospective Studies | 10 | 2011 | 54306 | 0.050 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2003 | 88 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2010 | 1512 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2004 | 412 | 0.050 |
Why?
|
| Cephalosporins | 1 | 1984 | 204 | 0.050 |
Why?
|
| Reoperation | 2 | 2009 | 4289 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 1990 | 1023 | 0.050 |
Why?
|
| Boston | 1 | 2016 | 9278 | 0.050 |
Why?
|
| Colonic Diseases | 1 | 1984 | 200 | 0.050 |
Why?
|
| Oxygen | 2 | 1988 | 4193 | 0.050 |
Why?
|
| Phosphates | 1 | 2006 | 772 | 0.050 |
Why?
|
| Ascitic Fluid | 2 | 2001 | 189 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 877 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
| Chymotrypsin | 1 | 2002 | 138 | 0.050 |
Why?
|
| Cholecystokinin | 1 | 2002 | 117 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2262 | 0.050 |
Why?
|
| Hemobilia | 1 | 1981 | 18 | 0.050 |
Why?
|
| Leg | 2 | 1984 | 1091 | 0.050 |
Why?
|
| Random Allocation | 5 | 1987 | 2394 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 58980 | 0.050 |
Why?
|
| Incidence | 3 | 2016 | 21391 | 0.050 |
Why?
|
| Body Weight | 7 | 2004 | 4611 | 0.050 |
Why?
|
| Radiopharmaceuticals | 2 | 2009 | 2634 | 0.050 |
Why?
|
| Bacterial Translocation | 1 | 2002 | 73 | 0.050 |
Why?
|
| Granular Cell Tumor | 1 | 2002 | 48 | 0.050 |
Why?
|
| Ultrasonography | 3 | 2009 | 5961 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 1988 | 1168 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2002 | 366 | 0.050 |
Why?
|
| Surgical Instruments | 1 | 1984 | 385 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2002 | 162 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2002 | 220 | 0.050 |
Why?
|
| Popliteal Artery | 1 | 1983 | 312 | 0.050 |
Why?
|
| Plasmids | 1 | 2006 | 2275 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2004 | 720 | 0.050 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2021 | 84 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2001 | 328 | 0.050 |
Why?
|
| Heat Stress Disorders | 1 | 2002 | 78 | 0.050 |
Why?
|
| Ribosomes | 3 | 1984 | 501 | 0.050 |
Why?
|
| Breast Neoplasms | 4 | 2002 | 21029 | 0.050 |
Why?
|
| Superoxide Dismutase | 3 | 1988 | 594 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 2011 | 1424 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2002 | 478 | 0.050 |
Why?
|
| Quinones | 1 | 2000 | 79 | 0.050 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2002 | 173 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 4496 | 0.040 |
Why?
|
| Shock, Hemorrhagic | 2 | 1980 | 223 | 0.040 |
Why?
|
| Palpation | 1 | 2000 | 166 | 0.040 |
Why?
|
| Hormones | 3 | 1990 | 867 | 0.040 |
Why?
|
| Thyroid Hormones | 2 | 2016 | 403 | 0.040 |
Why?
|
| Dogs | 7 | 1984 | 3841 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8623 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 491 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 1 | 1999 | 32 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2003 | 423 | 0.040 |
Why?
|
| Benzoquinones | 1 | 2000 | 198 | 0.040 |
Why?
|
| Chlorides | 1 | 2002 | 663 | 0.040 |
Why?
|
| Intestines | 2 | 2000 | 1907 | 0.040 |
Why?
|
| Ouabain | 2 | 1996 | 247 | 0.040 |
Why?
|
| Regeneration | 1 | 2008 | 1506 | 0.040 |
Why?
|
| Debridement | 1 | 2002 | 492 | 0.040 |
Why?
|
| Adenosylmethionine Decarboxylase | 2 | 1996 | 11 | 0.040 |
Why?
|
| Voice Quality | 1 | 2021 | 226 | 0.040 |
Why?
|
| Weight Loss | 1 | 2011 | 2684 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2001 | 575 | 0.040 |
Why?
|
| Glucagon | 4 | 1990 | 532 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1999 | 365 | 0.040 |
Why?
|
| Biological Transport, Active | 2 | 1997 | 327 | 0.040 |
Why?
|
| Spermidine | 2 | 1996 | 61 | 0.040 |
Why?
|
| Spermine | 2 | 1996 | 69 | 0.040 |
Why?
|
| Lactates | 7 | 1991 | 404 | 0.040 |
Why?
|
| Cholangiography | 1 | 1999 | 181 | 0.040 |
Why?
|
| Cathepsin D | 1 | 1998 | 59 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 1664 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 1 | 2000 | 315 | 0.040 |
Why?
|
| Transaminases | 2 | 1997 | 196 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2002 | 1130 | 0.040 |
Why?
|
| Nutritional Status | 2 | 1999 | 1607 | 0.040 |
Why?
|
| Infusions, Parenteral | 1 | 1998 | 399 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2005 | 1612 | 0.040 |
Why?
|
| Magnesium | 1 | 1982 | 810 | 0.040 |
Why?
|
| Adrenal Glands | 2 | 1993 | 554 | 0.040 |
Why?
|
| Body Surface Area | 1 | 1998 | 197 | 0.040 |
Why?
|
| Critical Illness | 1 | 2011 | 2709 | 0.040 |
Why?
|
| Imidazoles | 1 | 2004 | 1180 | 0.040 |
Why?
|
| Deoxyglucose | 1 | 1998 | 333 | 0.040 |
Why?
|
| Epinephrine | 4 | 1990 | 791 | 0.040 |
Why?
|
| Starvation | 2 | 1989 | 140 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2000 | 586 | 0.040 |
Why?
|
| Mannitol | 1 | 1998 | 180 | 0.040 |
Why?
|
| Methylamines | 1 | 1998 | 138 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 833 | 0.040 |
Why?
|
| Cushing Syndrome | 1 | 1999 | 241 | 0.040 |
Why?
|
| Tuberculosis, Female Genital | 1 | 1977 | 2 | 0.040 |
Why?
|
| Cytodiagnosis | 1 | 2021 | 442 | 0.040 |
Why?
|
| Nitrites | 2 | 1994 | 159 | 0.040 |
Why?
|
| Glutaminase | 1 | 1997 | 33 | 0.040 |
Why?
|
| Chloroquine | 1 | 1998 | 277 | 0.040 |
Why?
|
| Femur | 1 | 1983 | 1302 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9406 | 0.040 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 1999 | 231 | 0.040 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 1977 | 31 | 0.040 |
Why?
|
| Endometritis | 1 | 1977 | 49 | 0.040 |
Why?
|
| Carcinoma in Situ | 2 | 2000 | 796 | 0.030 |
Why?
|
| Growth Hormone | 1 | 1999 | 568 | 0.030 |
Why?
|
| Eflornithine | 1 | 1996 | 31 | 0.030 |
Why?
|
| Brain Diseases | 1 | 1986 | 1540 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2002 | 936 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 1999 | 406 | 0.030 |
Why?
|
| DNA Damage | 1 | 2006 | 2442 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 1999 | 398 | 0.030 |
Why?
|
| Isoflavones | 1 | 1997 | 136 | 0.030 |
Why?
|
| Albumins | 4 | 1992 | 577 | 0.030 |
Why?
|
| Nitrates | 2 | 1994 | 264 | 0.030 |
Why?
|
| United States | 2 | 2020 | 72448 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1997 | 179 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 1994 | 298 | 0.030 |
Why?
|
| Pancreatitis | 2 | 1999 | 1100 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 418 | 0.030 |
Why?
|
| Dopamine | 1 | 1983 | 1595 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1984 | 1469 | 0.030 |
Why?
|
| Oxygen Consumption | 4 | 2013 | 1843 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2002 | 1120 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 1055 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 1984 | 1439 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1995 | 273 | 0.030 |
Why?
|
| Back | 1 | 1995 | 64 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1999 | 768 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 1995 | 117 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2001 | 14374 | 0.030 |
Why?
|
| Intestine, Large | 1 | 1994 | 68 | 0.030 |
Why?
|
| Colonic Neoplasms | 2 | 2000 | 2526 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1998 | 1134 | 0.030 |
Why?
|
| Length of Stay | 4 | 1999 | 6476 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 2 | 1994 | 908 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1981 | 793 | 0.030 |
Why?
|
| Neoplasms, Second Primary | 1 | 2002 | 1060 | 0.030 |
Why?
|
| Ion Channels | 2 | 2013 | 1043 | 0.030 |
Why?
|
| Blood Pressure | 8 | 1984 | 8525 | 0.030 |
Why?
|
| Peptide YY | 1 | 1994 | 136 | 0.030 |
Why?
|
| Postoperative Period | 2 | 2002 | 1818 | 0.030 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1995 | 303 | 0.030 |
Why?
|
| Stomach | 1 | 1998 | 694 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 2 | 1984 | 180 | 0.030 |
Why?
|
| Carbon Radioisotopes | 3 | 1993 | 557 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2016 | 2007 | 0.030 |
Why?
|
| Mastectomy, Modified Radical | 1 | 1993 | 62 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1997 | 959 | 0.030 |
Why?
|
| Culture Media | 2 | 1986 | 900 | 0.030 |
Why?
|
| Lipolysis | 1 | 2014 | 211 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1996 | 562 | 0.030 |
Why?
|
| Morbidity | 1 | 1999 | 1765 | 0.030 |
Why?
|
| Adenocarcinoma | 3 | 2011 | 6316 | 0.030 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 979 | 0.030 |
Why?
|
| Biopsy | 3 | 1999 | 6771 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 4 | 1993 | 415 | 0.030 |
Why?
|
| Duodenum | 1 | 1976 | 486 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 1997 | 1146 | 0.030 |
Why?
|
| Adolescent | 6 | 2016 | 87809 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 58748 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1996 | 568 | 0.030 |
Why?
|
| Cardiac Output | 3 | 1984 | 838 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2003 | 4089 | 0.030 |
Why?
|
| Gastroenterology | 1 | 1999 | 571 | 0.030 |
Why?
|
| Microtubules | 1 | 1998 | 1072 | 0.030 |
Why?
|
| Pyridines | 1 | 2004 | 2879 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2002 | 11070 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 1997 | 1039 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 2014 | 3300 | 0.020 |
Why?
|
| Brain | 2 | 1997 | 26951 | 0.020 |
Why?
|
| Cross Infection | 1 | 1981 | 1434 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2005 | 14661 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 1992 | 573 | 0.020 |
Why?
|
| Laparotomy | 2 | 1984 | 465 | 0.020 |
Why?
|
| Cell Separation | 1 | 1997 | 1720 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1993 | 956 | 0.020 |
Why?
|
| Survival Rate | 2 | 2004 | 12810 | 0.020 |
Why?
|
| Glucose | 4 | 1997 | 4350 | 0.020 |
Why?
|
| Cholecystitis | 2 | 1999 | 181 | 0.020 |
Why?
|
| Myocardium | 3 | 1997 | 4700 | 0.020 |
Why?
|
| Solutions | 2 | 1988 | 419 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2000 | 3682 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1994 | 1752 | 0.020 |
Why?
|
| Maleates | 1 | 1990 | 18 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 1990 | 35 | 0.020 |
Why?
|
| Breast Diseases | 1 | 1993 | 443 | 0.020 |
Why?
|
| Guinea Pigs | 2 | 1996 | 1316 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 1984 | 1095 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2002 | 3905 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 4938 | 0.020 |
Why?
|
| DNA Probes | 1 | 1991 | 551 | 0.020 |
Why?
|
| Cobalt | 1 | 1990 | 155 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1994 | 1347 | 0.020 |
Why?
|
| Probability | 1 | 1995 | 2475 | 0.020 |
Why?
|
| Eating | 4 | 1990 | 1539 | 0.020 |
Why?
|
| Extremities | 1 | 1995 | 867 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1992 | 1155 | 0.020 |
Why?
|
| Myosins | 1 | 1991 | 405 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1304 | 0.020 |
Why?
|
| Pancreas | 1 | 1976 | 1677 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1990 | 433 | 0.020 |
Why?
|
| Apoptosis | 1 | 2005 | 9497 | 0.020 |
Why?
|
| Monokines | 1 | 1988 | 71 | 0.020 |
Why?
|
| Inflammation | 2 | 2000 | 10755 | 0.020 |
Why?
|
| Free Radicals | 1 | 1988 | 238 | 0.020 |
Why?
|
| Catalase | 1 | 1988 | 216 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2021 | 3531 | 0.020 |
Why?
|
| Alanine Transaminase | 3 | 1992 | 607 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2000 | 10185 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 1827 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1988 | 6498 | 0.020 |
Why?
|
| Body Water | 1 | 1988 | 341 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1991 | 772 | 0.020 |
Why?
|
| Risk | 3 | 1984 | 9632 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3825 | 0.020 |
Why?
|
| Orosomucoid | 3 | 1992 | 47 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1970 | 475 | 0.020 |
Why?
|
| Infusions, Intravenous | 2 | 1989 | 2235 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15840 | 0.020 |
Why?
|
| Cell Division | 1 | 1994 | 4463 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1999 | 5132 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2004 | 2014 | 0.020 |
Why?
|
| Laparoscopy | 1 | 1999 | 2147 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39262 | 0.020 |
Why?
|
| Age Factors | 6 | 2002 | 18413 | 0.020 |
Why?
|
| Adipocytes | 1 | 2013 | 1179 | 0.020 |
Why?
|
| Goiter, Nodular | 1 | 1986 | 28 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2698 | 0.020 |
Why?
|
| Mutation | 2 | 2002 | 29957 | 0.020 |
Why?
|
| Toxins, Biological | 1 | 1986 | 61 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 1980 | 2942 | 0.020 |
Why?
|
| Chromones | 1 | 2005 | 149 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 1988 | 554 | 0.020 |
Why?
|
| Radiography | 4 | 1983 | 6965 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 1985 | 201 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1990 | 1201 | 0.020 |
Why?
|
| Drainage | 2 | 1981 | 1161 | 0.020 |
Why?
|
| Clinical Trials as Topic | 3 | 1987 | 8055 | 0.020 |
Why?
|
| Antisepsis | 1 | 1984 | 16 | 0.020 |
Why?
|
| Calcinosis | 1 | 1993 | 1476 | 0.020 |
Why?
|
| Phosphocreatine | 3 | 1992 | 261 | 0.010 |
Why?
|
| Linear Models | 1 | 1995 | 5877 | 0.010 |
Why?
|
| Heart Rate | 3 | 1986 | 4180 | 0.010 |
Why?
|
| Adrenalectomy | 3 | 1993 | 348 | 0.010 |
Why?
|
| Diaphragm | 1 | 1986 | 351 | 0.010 |
Why?
|
| Salicylates | 1 | 2004 | 127 | 0.010 |
Why?
|
| Torsion Abnormality | 1 | 1984 | 91 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2013 | 2532 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 1988 | 656 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1987 | 559 | 0.010 |
Why?
|
| Abdomen, Acute | 1 | 1984 | 122 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1980 | 4319 | 0.010 |
Why?
|
| Tryptophan | 1 | 1986 | 479 | 0.010 |
Why?
|
| Pyruvic Acid | 2 | 1996 | 195 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8556 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1985 | 564 | 0.010 |
Why?
|
| Kidney | 1 | 1999 | 7064 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 251 | 0.010 |
Why?
|
| Actins | 1 | 1991 | 2049 | 0.010 |
Why?
|
| Clinical Competence | 1 | 1999 | 4783 | 0.010 |
Why?
|
| Mammaplasty | 1 | 1993 | 1240 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1986 | 2558 | 0.010 |
Why?
|
| Magnesium Chloride | 1 | 1982 | 30 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 2 | 1984 | 945 | 0.010 |
Why?
|
| Morpholines | 1 | 2005 | 583 | 0.010 |
Why?
|
| Fever | 1 | 1990 | 1617 | 0.010 |
Why?
|
| Portal Vein | 1 | 1985 | 429 | 0.010 |
Why?
|
| Regional Blood Flow | 2 | 1983 | 1490 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1986 | 663 | 0.010 |
Why?
|
| Creatinine | 1 | 1987 | 1904 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2003 | 393 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2002 | 364 | 0.010 |
Why?
|
| Bronchopneumonia | 1 | 1981 | 11 | 0.010 |
Why?
|
| Rhodamines | 1 | 2001 | 179 | 0.010 |
Why?
|
| Acute Disease | 3 | 1999 | 7268 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1982 | 325 | 0.010 |
Why?
|
| Keratins | 1 | 2002 | 497 | 0.010 |
Why?
|
| Lipoma | 1 | 1983 | 292 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1984 | 933 | 0.010 |
Why?
|
| Acetylcholinesterase | 2 | 1970 | 156 | 0.010 |
Why?
|
| Aging | 1 | 1999 | 8652 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1984 | 752 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2021 | 64981 | 0.010 |
Why?
|
| Rupture | 1 | 1981 | 443 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1980 | 109 | 0.010 |
Why?
|
| Veins | 1 | 1984 | 765 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 1981 | 143 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 522 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 13308 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24102 | 0.010 |
Why?
|
| Edema | 1 | 1984 | 770 | 0.010 |
Why?
|
| Candidiasis | 1 | 2002 | 363 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1984 | 1064 | 0.010 |
Why?
|
| Oxidants | 1 | 2000 | 169 | 0.010 |
Why?
|
| Digestive System Diseases | 1 | 1981 | 151 | 0.010 |
Why?
|
| Biological Products | 1 | 1988 | 916 | 0.010 |
Why?
|
| Swine | 3 | 1987 | 5899 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2000 | 211 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2000 | 252 | 0.010 |
Why?
|
| Acyltransferases | 2 | 1970 | 305 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 1992 | 3959 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 22020 | 0.010 |
Why?
|
| Sirolimus | 1 | 2005 | 1547 | 0.010 |
Why?
|
| Blood Glucose | 5 | 1991 | 6379 | 0.010 |
Why?
|
| Biliary Tract Diseases | 1 | 1999 | 157 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1987 | 1869 | 0.010 |
Why?
|
| Blood Volume | 1 | 1979 | 550 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1983 | 733 | 0.010 |
Why?
|
| Monensin | 1 | 1996 | 30 | 0.010 |
Why?
|
| Urinary Fistula | 1 | 1977 | 43 | 0.010 |
Why?
|
| Aerobiosis | 1 | 1996 | 101 | 0.010 |
Why?
|
| Sex Factors | 2 | 1982 | 10546 | 0.010 |
Why?
|
| Intestinal Polyps | 1 | 1977 | 104 | 0.010 |
Why?
|
| Suture Techniques | 1 | 1981 | 790 | 0.010 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 1996 | 76 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2005 | 2058 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 2298 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11481 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2002 | 1504 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1993 | 9278 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1979 | 1631 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1997 | 41337 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 1977 | 311 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2002 | 2943 | 0.010 |
Why?
|
| Alanine | 1 | 1996 | 606 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2002 | 2210 | 0.010 |
Why?
|
| Mastectomy, Simple | 1 | 1993 | 23 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2002 | 3618 | 0.010 |
Why?
|
| Mastectomy | 1 | 2002 | 1832 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1995 | 825 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1984 | 4902 | 0.010 |
Why?
|
| Axonal Transport | 2 | 1970 | 178 | 0.010 |
Why?
|
| Abscess | 1 | 1977 | 605 | 0.010 |
Why?
|
| Hypoglossal Nerve | 2 | 1970 | 100 | 0.010 |
Why?
|
| Weight Gain | 2 | 1995 | 2347 | 0.010 |
Why?
|
| Glycolysis | 1 | 1996 | 828 | 0.010 |
Why?
|
| Research Design | 1 | 1988 | 6180 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1981 | 1462 | 0.010 |
Why?
|
| Potassium | 1 | 1996 | 1313 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1981 | 1181 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9530 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1996 | 2502 | 0.010 |
Why?
|
| Pyruvates | 1 | 1991 | 84 | 0.010 |
Why?
|
| Antioxidants | 1 | 2000 | 1667 | 0.010 |
Why?
|
| Bile | 1 | 1992 | 296 | 0.010 |
Why?
|
| Immune Sera | 1 | 1992 | 613 | 0.010 |
Why?
|
| Colectomy | 1 | 1977 | 692 | 0.010 |
Why?
|
| Sodium | 1 | 1996 | 1594 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1996 | 1167 | 0.010 |
Why?
|
| Vagus Nerve | 2 | 1970 | 457 | 0.010 |
Why?
|
| Cytoplasmic Streaming | 1 | 1970 | 5 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1990 | 71 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1970 | 311 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 3486 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8552 | 0.010 |
Why?
|
| Catecholamines | 1 | 1991 | 385 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1984 | 12427 | 0.010 |
Why?
|
| Calcium Radioisotopes | 1 | 1989 | 9 | 0.010 |
Why?
|
| Cranial Nerves | 1 | 1970 | 98 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1970 | 459 | 0.010 |
Why?
|
| Autoradiography | 1 | 1970 | 730 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1989 | 187 | 0.010 |
Why?
|
| Learning | 1 | 1999 | 1739 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 6465 | 0.010 |
Why?
|
| Parenteral Nutrition Solutions | 1 | 1988 | 30 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 1628 | 0.000 |
Why?
|
| Verapamil | 1 | 1989 | 242 | 0.000 |
Why?
|
| Peritoneal Cavity | 1 | 1989 | 138 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 8950 | 0.000 |
Why?
|
| Menopause | 1 | 1977 | 1640 | 0.000 |
Why?
|
| Organ Culture Techniques | 1 | 1991 | 796 | 0.000 |
Why?
|
| Glycogen | 1 | 1989 | 251 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1996 | 2611 | 0.000 |
Why?
|
| Electrolytes | 1 | 1988 | 274 | 0.000 |
Why?
|
| Blood | 1 | 1990 | 586 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1980 | 3612 | 0.000 |
Why?
|
| Rabbits | 2 | 1970 | 4773 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 660 | 0.000 |
Why?
|
| Foot | 1 | 1991 | 573 | 0.000 |
Why?
|
| Transferrin | 1 | 1988 | 284 | 0.000 |
Why?
|
| Phenotype | 1 | 2004 | 16548 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1993 | 1328 | 0.000 |
Why?
|
| Suction | 1 | 1987 | 263 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1273 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1987 | 641 | 0.000 |
Why?
|
| Rest | 1 | 1991 | 914 | 0.000 |
Why?
|
| Ultrasonic Therapy | 1 | 1987 | 215 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1990 | 1428 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36286 | 0.000 |
Why?
|
| Platelet Count | 1 | 1987 | 777 | 0.000 |
Why?
|
| Surgical Flaps | 1 | 1993 | 1669 | 0.000 |
Why?
|
| Lymph | 1 | 1984 | 77 | 0.000 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1984 | 132 | 0.000 |
Why?
|
| Endarterectomy | 1 | 1984 | 195 | 0.000 |
Why?
|
| Glucosephosphates | 1 | 1982 | 20 | 0.000 |
Why?
|
| Glucose-6-Phosphate | 1 | 1982 | 29 | 0.000 |
Why?
|
| Registries | 1 | 1999 | 8458 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 20509 | 0.000 |
Why?
|
| Cholelithiasis | 1 | 1984 | 408 | 0.000 |
Why?
|
| Axons | 1 | 1970 | 1672 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1990 | 1803 | 0.000 |
Why?
|
| Abdomen | 1 | 1988 | 1130 | 0.000 |
Why?
|
| Pressure | 1 | 1984 | 1156 | 0.000 |
Why?
|
| Laser Therapy | 1 | 1987 | 1089 | 0.000 |
Why?
|
| Capillary Permeability | 1 | 1984 | 768 | 0.000 |
Why?
|
| Microchemistry | 1 | 1979 | 55 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1979 | 234 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1979 | 297 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1993 | 11152 | 0.000 |
Why?
|
| Pregnancy | 1 | 1980 | 29746 | 0.000 |
Why?
|
| Child | 2 | 1983 | 79799 | 0.000 |
Why?
|
| Coronary Artery Bypass | 1 | 1984 | 2272 | 0.000 |
Why?
|
| Hospitalization | 1 | 1983 | 10789 | 0.000 |
Why?
|